How much has Equip Health raised?

Equip Health has $156M-$160M reported in disclosed or reported funding. The profile lists only public amounts and clearly marks undisclosed valuations or rounds.

The major funding entries are 2021 Series A: early growth capital, valuation not disclosed, led/backed by Optum Ventures, General Catalyst, and others; Feb 2022 Series B: $58M, valuation not disclosed, led/backed by .406 Ventures and Optum Ventures; Apr 2024 Series C: $35M, valuation not disclosed, led/backed by General Catalyst, Optum Ventures, Tiger Global, and others reported; Jul 2025 Late venture: $46.6M, valuation not disclosed, led/backed by 11 investors in SEC filing.

Notable investors or backers include Optum Ventures, General Catalyst, and others, .406 Ventures and Optum Ventures, General Catalyst, Optum Ventures, Tiger Global, and others reported, 11 investors in SEC filing. These investors are relevant because they shape board expectations around growth, governance, hiring, and follow-on capital discipline.

No current valuation is public, so there is no reliable valuation movement to analyze. The better signal is the company's stage, funding recency, customer or care footprint, and hiring momentum.

Equip Health has not publicly disclosed audited profitability or IPO timing. Treat IPO readiness as speculative until management files, announces a transaction, or publishes financials.

The funding signal suggests budget capacity, but not automatic spend. Sellers should map to the active initiative funded by the round: market expansion, clinical operations, AI/data tooling, compliance, workforce, integrations, or payer/provider partnerships.